Company Overview of Embrex Inc.
Embrex Inc., a biotechnology company, develops, sale, and lease biological and mechanical products for the poultry industry in the United States and internationally. The company offers the Inovoject system, a proprietary, automated in-the-egg injection system, which can process 20,000 to 70,000 eggs per hour and eliminates the need for manual, post-hatch injection of certain vaccines. The company also markets the Egg Remover system to remove infertile and early-dead eggs from incubator trays prior to transfer to the hatching incubator or inoculation through the Inovoject system; and the Vaccine Saver option for the Inovoject system, which identifies infertile and early-dead eggs, and selecti...
1040 Swabia Court
Durham, NC 27703-8481
Founded in 1985
Key Executives for Embrex Inc.
Principal Financial Officer
Vice President of Investor Relations and Corporate Communications
Vice President of Global Product Development and Supply and Director of Embrex Latin America
Vice President of North America
Manager of Facilities & Maintenance for the new Inovocox(TM) Manufacturing Facility
Compensation as of Fiscal Year 2014.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries